The transcription factor nuclear factor κB (NF-κB) is constitutively active in the murine osteosarcoma cell line, LM8. Parthenolide (Par), a sesquiterpene lactone, has been reported to show antitumor activity through inhibition of the NF-κB DNA binding and other mechanisms. In this study, we investigated the radio-sensitizing activity of Par in vitro and in animal models by s.c. inoculation of Luc -LM8, a stable transfectant of NF-κB reporter construct into LM8.
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In the proliferation assay, RT significantly inhibited growth of Luc-LM8 cells. Although Par alone did not alter the cell growth, Par significantly enhanced the growth inhibitory effect of RT at every dose tested ( Fig.2a ). Furthermore, Par induced apopto sis of Luc LM8 cells in vitro synergistically with RT ( Fig.2b ). 
Discussion
In the current study, Par suppressed Luc-LM8 cell growth, induced apoptosis in vitro, and inhibited tumor growth in vivo synergistically with irradiation treatment, suggesting that Par sensitized Luc-LM8 to irradiation. It is conceivable that the mechanism of radio-sensitization might be the inhibition of NF-κB activity because NF-κB has been shown to be associated with cancer resistance to RT. In addition, Par improved the prognosis of the mice bearing osteosarcoma treated with local RT, although the mechanism of this observation needs to be elucidated. Par might be a hopeful candidate for a potent radiosensitizing drug for cancer radiotherapy.
